Granted, it’s only one seat, but critics of Facebook’s board of directors bemoaning the lack of women, aside from Chief Operating Officer Sheryl Sandberg, will likely welcome the addition of University of California, San Francisco Chancellor Susan Desmond-Hellmann.
Desmond-Hellmann oversees all aspects of the university and medical center’s strategy and operations. Prior to USF, she served as president, product development at biotechnology company Genentech.
She also serves on the board of directors for Procter & Gamble, and as a trustee for nonprofit medical research organization the Howard Hughes Medical Institute.
The rest of Facebook’s board of directors is:
- Co-Founder and CEO Mark Zuckerberg
- Marc Andreessen, co-founder of Andreessen Horowitz
- Erskine Bowles, president emeritus, University of North Carolina
- James Breyer, Accel Partners
- Donald Graham, chairman and CEO, The Washington Post Co.
- Reed Hastings, chairman and CEO, Netflix
- Peter Thiel, Founders Fund
Sue has a great track record of building and managing a diverse set of organizations, so her insights will be valuable as we continue to expand into new areas. Her experience shaping public policy and operating public companies fits well with the rest of the board and will make us an even stronger company.
And Desmond-Hellmann added:
I’ve always been drawn to organizations that do ground-breaking work. Facebook has an ambitious mission and long-term vision of innovation that is transforming how people connect with one another. I’m proud to be part of a company that is serving such an important purpose in the world.
Readers: Is Desmond-Hellmann a good addition to Facebook’s board of directors?